Article Information
- Received November 25, 2019
- Revision received March 19, 2020
- Accepted March 22, 2020
- Published online April 16, 2020.
Author Information
- Matthias Fritsche1,
- Robrecht P. R. D. van der Wel2,
- Robin Smit3,
- Bastiaan R. Bloem3,
- Ivan Toni1 and
- Rick C. Helmich1,3
- 1Centre for Cognitive Neuroimaging, Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen 6525 EN, The Netherlands
- 2Department of Psychology, Rutgers University, Camden, NJ 08102
- 3Donders Institute for Brain, Cognition and Behaviour; Department of Neurology; Center of Expertise for Parkinson & Movement Disorders, Radboud University Medical Center, Nijmegen 6525 GC, The Netherlands
- Correspondence should be addressed to Matthias Fritsche at m.fritsche{at}donders.ru.nl.
Author contributions
Author contributions: R.P.R.D.v.d.W., B.R.B., I.T., and R.C.H. designed research; R.P.R.D.v.d.W. and R.S. performed research; M.F. and R.P.v.d.W. analyzed data; M.F., R.P.R.D.v.d.W., I.T., and R.C.H. wrote the paper.
Disclosures
M.F., R.P.R.D.v.d.W., R.S., and I.T. declare no competing interests. R.C.H. serves on the clinical advisory board of Cadent Therapeutics and received honoraria from AbbVie. B.R.B currently serves as Associate Editor for the Journal of Parkinson’s Disease, serves on the editorial of Practical Neurology and Digital
Biomarkers, has received honoraria from serving on the scientific advisory board for Abbvie, Biogen, UCB, and Walk with Path, and has received fees for speaking at conferences from AbbVie, Zambon, Roche, GE Healthcare, and Bial.
R.C.H. was funded by the VENI grant from the Netherlands Organization for Scientific Research 91617077. The Center of Expertise for Parkinson & Movement Disorders of the Radboud university medical center was supported by a Center of Excellence Grant of the Parkinson’s Foundation. B.R.B. was supported by the Netherlands Organization for Scientific Research, the Michael J Fox Foundation, UCB, Abbvie, the Stichting Parkinson Fonds, the Hersenstichting Nederland, the Parkinson’s Foundation, Verily Life Sciences, Horizon 2020, the Topsector Life Sciences and Health, and the Parkinson Vereniging.
Funding
Netherlands Organization for Scientific Research
91617077Parkinson's Foundation
Michael J. Fox Foundation for Parkinson's Research (MJFF)
UCB
AbbVie (Abbvie)
Stichting ParkinsonFonds
Hersenstichting (Hersenstichting Nederland)
Verily Life Sciences
EC | Horizon 2020 (EU Framework Programme for Research and Innovation)
Topsector Life Sciences and Health
Parkinson Vereniging
Other Version
- You are viewing the most recent version of this article.
- previous version (April 16, 2020).
Online Impact